Refine Search
(2)
(17)
(49)
(94)

Immunology

GlobalData provides unique and market-leading data and insights into the immunology market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • January 2019
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is an autoimmune disease that, due to a complex interplay of environmental, immunological, and genetic factors, causes chronic inflammation and progressive deformity of the joints over time.

In 2017, the diagnose...

Rheumatoid Arthritis: Epidemiology Forecast to 2027

  • $3,995
  • January 2019
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the body’s immu...

Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • December 2018
Add to Basket Quick View Add to Saved List

Psoriasis is an incurable, chronic and systemic inflammatory skin disorder with a prevalence of 2–3% worldwide. The exact causes of psoriasis is unknown, although it is believed that environmental factors, skin barrier disruptions, and immune d...

Plaque Psoriasis: Epidemiology Forecast to 2027

  • $3,995
  • December 2018
Add to Basket Quick View Add to Saved List

Plaque psoriasis is a chronic immune-mediated skin disease characterized by red, flaky patches that are itchy and sometimes painful. Psoriatic plaques are formed due to an increased production of skin cells; normally the process to make and rep...

Cat Allergy Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cat Allergy Global Clinical Trials Review, H2, 2018" provides an overview of Cat Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Cat Allergy. ...

Competitor Landscape: Graft Versus Host Disease (GVHD)

  • $6,400
  • November 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the graft versus host disease (GVHD) market, analysis of current & potential future product positioning, and forecast approval dates (by q...

Competitor Landscape: Sjögren's Syndrome

  • $6,400
  • November 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Sjögren's Syndrome market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) fo...

Competitor Landscape: Systemic Sclerosis (Scleroderma)

  • $6,400
  • November 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Systemic Sclerosis (Scleroderma) market, analysis of current & potential future product positioning, and forecast approval dates (by q...

Birch Pollen Allergy Global Clinical Trials Review, H2, 2018

  • $2,500
  • November 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Birch Pollen Allergy Global Clinical Trials Review, H2, 2018" provides an overview of Birch Pollen Allergy clinical trials scenario. This report provides top line data relating to the clinical trial...

Competitor Landscape: Psoriasis

  • $6,400
  • October 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Psoriasis (PsO) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candi...

Competitor Landscape: Rheumatoid Arthritis

  • $6,400
  • October 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Rheumatoid Arthritis (RA) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter)...

Competitor Landscape: Lupus

  • $6,400
  • October 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Lupus market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in P...

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2018" provides an overview of Wiskott-Aldrich Syndrome clinical trials scenario. This report provides top line data relating to the clinic...

X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “X-Linked Agammaglobulinemia Global Clinical Trials Review, H2, 2018" provides an overview of X-Linked Agammaglobulinemia clinical trials scenario. This report provides top line data relating to the ...

Allergies Global Clinical Trials Review, H2, 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Allergies Global Clinical Trials Review, H2, 2018" provides an overview of Allergies clinical trials scenario. This report provides top line data relating to the clinical trials on Allergies. Report...

Join our mailing list
Find out first about the latest reports and offers.